Viridian Therapeutics, Inc.\DE (VRDN) Interest Coverage Ratio (2013 - 2026)

Viridian Therapeutics, Inc.\DE's Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 33.56 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 80.34% year-over-year to 33.56 in Q1 2026; TTM through Mar 2026 was 49.11, a 75.42% increase from a year earlier, with the FY2025 full-year figure at 1.15, up 20.02% from the prior year.
• Interest Coverage Ratio rose to 33.56 in Q1 2026 per VRDN's latest filing, from 37.4 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 1962.64 in Q4 2022 and bottomed at 624.8 in Q4 2024.
• The 5-year median for Interest Coverage Ratio is 103.14 (2024), against an average of 28.49.
• Across the five-year window, Interest Coverage Ratio jumped 1449.77% in 2022 and slumped 1228.72% in 2025, its largest moves.
• Year by year, Interest Coverage Ratio stood at 1962.64 in 2022, then plunged by 109.1% to 178.7 in 2023, then slumped by 249.65% to 624.8 in 2024, then jumped by 94.01% to 37.4 in 2025, then gained by 10.28% to 33.56 in 2026.
• Per Business Quant, the three latest VRDN Interest Coverage Ratio figures stand at 33.56 (Q1 2026), 37.4 (Q4 2025), and 71.45 (Q3 2025).